HIGHLIGHTS

– Livac receives Medical Device Single Audit Program (MDSAP) certification for Australia, USA, and Canada
– Livac to attend ASMBS in Dallas, Texas in June
– Managing Director invited guest & panel member at ATC, Actuator & AusMedtech

Livac USA, Inc. Appoints a Chief Commercial Officer

Livac USA, Inc. welcomes Tom Lucas as Chief Commercial Officer, USA.

Australia & New Zealand – LiVac Sales & Distribution

New, non-metal, solid organ retractor saves time and simplifies procedures for surgeons, reduces painful scarring, and improves recovery through use of gentle suction.

MINNEAPOLIS – Livac USA, Inc. announced today that its LiVac Retractor is now being used by surgeons in the United States. The LiVac Retractor, which has received FDA approval for use as a solid organ retractor in the United States, is a gentle, non-metal retractor that simplifies robotic and laparoscopic procedures and saves time for physicians, while improving the recovery process and reducing the reliance on opioids for patients. It is the only retractor which retracts the upper surface of the liver (or spleen).

Livac welcomes new Board Director

We are pleased to announce the appointment of Mr Philip Nowell to the Livac board of directors as Non-Executive Director and Chair. This appointment is effective from 1 September 2021 and continues on from Mr Nowell’s engagement with the Company, as a strategic advisor since 2020.

USA – First successful patient case

The first successful patient case using the LiVac™ Retractor has taken place in the USA.